Cutaneous side-effects of the potential COVID-19 drugs.

Türsen, Ümit; Türsen, Belma; Lotti, Torello

Türsen, Ümit; Türsen, Belma; Lotti, Torello.

Türsen Ü; Department of Dermatology, School of Medicine, Mersin University, Mersin, Turkey.
Türsen B; Department of Health Science, Toros University, Mersin, Turkey.
Lotti T; Department of Dermatology, School of Medicine, Marconi University, Rome, Italy.

Dermatol Ther ; 33(4): e13476, 2020 Jul.

Article in English | MEDLINE | ID: covidwho-944657

ABSTRACT

ABSTRACT

COVID-19 disease is a highly contagious and particularly popular problem in all countries. A variety of repurposed drugs and investigational drugs such as remdesivir, chloroquine, hydroxychloroquine, ritonavir, lopinavir, interferon-beta, and other potential drugs have been studied for COVID19 treatment. We reviewed the potential dermatological side-effects of these drugs.

Subject(s)

Antiviral Agents/adverse effects; Betacoronavirus; Coronavirus Infections/drug therapy; Drug-Related Side Effects and Adverse Reactions/epidemiology; Pandemics; Pneumonia, Viral/drug therapy; Skin Diseases/chemically induced; Antiviral Agents/therapeutic use; COVID-19; Coronavirus Infections/epidemiology; Global Health; Humans; Incidence; Pneumonia, Viral/epidemiology; SARS-CoV-2; Skin Diseases/epidemiology; COVID-19 Drug Treatment

Keywords

COVID-19; dermatology; side-effects; skin

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Skin Diseases / Coronavirus Infections / Drug-Related Side Effects and Adverse Reactions / Pandemics / Betacoronavirus Type of study: Experimental Studies / Observational study Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.13476

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google